In the last trading session, 1,176,169 shares of the Mustang Bio, Inc. (NASDAQ:MBIO) were traded, and its beta was 1.75. Most recently the company’s share price was $3.33, and it changed around $0.01 or 0% from the last close, which brings the market valuation of the company to $283.63 Million. MBIO currently trades at a discount to its 52-week high of $5.22, offering almost -56.76% off that amount. The share price’s 52-week low was $2.41, which indicates that the current value has risen by an impressive 27.63% since then. We note from Mustang Bio, Inc.’s average daily trading volume that its 10-day average is 2.02 Million shares, with the 3-month average coming to 3.01 Million.
Mustang Bio, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 1.7. If we narrow it down even further, the data shows that none out of 4 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended MBIO as a Hold, whereas 4 deemed it a Buy, and no one rated it as Underweight. Mustang Bio, Inc. is expected to report earnings per share of -$0.19 for the current quarter.
Mustang Bio, Inc. (NASDAQ:MBIO): Trading Information
Instantly MBIO has showed a green trend with a performance of 0.3% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of $3.42- on Tuesday, Apr 06 increased the stock’s daily price by 2.63%. The company’s shares are currently down -0.12% year-to-date, but still up 0.0847 over the last five days. On the other hand, Mustang Bio, Inc. (NASDAQ:MBIO) is 0.05% up in the 30-day period. We can see from the shorts that 2.95 Million shares have been sold at a short interest cover period of 0.98 day (s).
The consensus price target as assigned by Wall Street analysts is $10.25, which translates to bears needing to increase their stock price by 207.81% from its current value. Analyst projections state that MBIO is forecast to be at a low of $7 and a high of $13. In order for the stock price to hit the forecast high, the stock would need to surge +290.39% from its current level, while the stock would need to crash 110.21% from its current level to reach the projected low.
Mustang Bio, Inc. (MBIO) projections and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -45.2%. Mustang Bio, Inc. earnings are expected to increase by 11.3% in 2021, but the outlook is negative 0% per year for the next five years.
Mustang Bio, Inc. (NASDAQ:MBIO)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 17.45% of Mustang Bio, Inc. shares, and 25.12% of them are in the hands of institutional investors. The stock currently has a share float of 30.43%. Mustang Bio, Inc. stock is held by 125 institutions, with Blackrock Inc. being the largest institutional investor. By Dec 30, 2020, it held 3.97% of the shares, which is about 3.34 Million shares worth $12.66 Million.
Vanguard Group, Inc. (The), with 2.57% or 2.16 Million shares worth $8.19 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
iShares Russell 2000 ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Feb 27, 2021. The former held 1317086 shares worth $4.65 Million, making up 1.56% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.25 Million shares worth around $4.74 Million, which represents about 1.48% of the total shares outstanding.